|
Apr 1
|
Omeros Corp (OMER) Reports Fourth Quarter and Year-End 2023 Financial Results
|
|
Apr 1
|
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
|
|
Mar 27
|
Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on April 1, 2024
|
|
Mar 17
|
Sleeping Giants: 3 Picks With Massive Upside by Mid-Decade
|
|
Feb 1
|
Omeros Corporation Announces Additional Royalty Monetization with DRI Healthcare Trust
|
|
Jan 10
|
Brian's Big Idea on Biotech
|
|
Nov 6
|
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023
|
|
Nov 3
|
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
|
|
Nov 2
|
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
|